Literature DB >> 4403715

Handbook of materials and methods.

.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4403715     DOI： 10.1016/0014-2964(72)90043-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.

Authors:  G Mathé; M Bayssas; J Gouveia; D Dantchev; P Ribaud; D Machover; J L Misset; L Schwarzenberg; C Jasmin; M Hayat
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.